C11orf61_BC024479 Activators
C11orf61_BC024479 can influence its activity through a variety of cellular signaling pathways. Forskolin, by elevating intracellular cAMP levels, leads to the activation of cAMP-dependent protein kinase A (PKA). This kinase can phosphorylate C11orf61_BC024479, which enhances the protein's functional activity. Similarly, isoproterenol, a beta-adrenergic agonist, also raises cAMP levels and consequently activates PKA, which may then target C11orf61_BC024479 for activation. Another cAMP analog, Dibutyryl-cAMP, directly activates PKA, potentially facilitating the phosphorylation and activation of C11orf61_BC024479. Ionomycin, on the other hand, increases intracellular calcium concentrations, which triggers calcium-dependent protein kinases that may activate C11orf61_BC024479 through phosphorylation.
In parallel, Phorbol 12-myristate 13-acetate (PMA) engages protein kinase C (PKC) which can phosphorylate and activate C11orf61_BC024479 if it is within PKC's substrate range. The protein C11orf61_BC024479 could also be regulated by growth factor signaling, as evidenced by Epidermal Growth Factor (EGF) and Vascular Endothelial Growth Factor (VEGF), which activate the MAPK/ERK and PI3K/AKT signaling pathways, respectively. These pathways are known for their roles in phosphorylation events that can modulate protein activity. Anisomycin acts as a JNK and p38 activator, which also converges on the MAPK/ERK pathway, presenting another route by which C11orf61_BC024479 can be activated. Calyculin A's inhibition of phosphatases PP1 and PP2A prevents the dephosphorylation of proteins, which may result in the sustained activation of C11orf61_BC024479 if it is usually regulated by these phosphatases. Lastly, Lithium Chloride's inhibition of GSK-3 leads to the activation of the Wnt signaling pathway, which may upregulate C11orf61_BC024479 activity, and Retinoic Acid, by modulating gene transcription, can influence signaling pathways that regulate the activity of C11orf61_BC024479.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate C11orf61_BC024479 through calcium-dependent signaling pathways. Calcium can activate calmodulin-dependent kinases or other calcium-sensitive proteins that may interact with and activate C11orf61_BC024479. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can lead to the phosphorylation and activation of C11orf61_BC024479 if it is a substrate of PKC or part of a PKC-regulated signaling pathway. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a beta-adrenergic agonist, can activate the beta-adrenergic receptors leading to the activation of adenylyl cyclase and an increase in cAMP levels. This rise in cAMP can subsequently activate PKA, which could phosphorylate and activate C11orf61_BC024479 as part of the signaling cascade. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K/AKT signaling pathway, which can lead to the activation of downstream targets including C11orf61_BC024479, if it is part of this signaling cascade or indirectly influenced by the pathway's modulation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates the MAPK/ERK pathway by acting as a JNK and p38 activator. This activation can lead to the phosphorylation of substrates involved in the pathway, potentially including C11orf61_BC024479 if it is a part of this signaling network. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is a potent inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A), which leads to increased phosphorylation levels of proteins. If C11orf61_BC024479 is regulated by dephosphorylation through PP1 or PP2A, inhibition by Calyculin A would result in its sustained activation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that activates PKA. PKA can then activate C11orf61_BC024479 through phosphorylation if the protein is a target of PKA-mediated signaling. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid binds to retinoic acid receptors which can regulate gene transcription and modulate signaling pathways. Activation of these pathways can lead to the activation of C11orf61_BC024479 if it is a part of the affected signaling network. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits glycogen synthase kinase 3 (GSK-3). Inhibition of GSK-3 can lead to the activation of the Wnt signaling pathway, and if C11orf61_BC024479 is a part of or regulated by the components of the Wnt pathway, its activity could be upregulated as a consequence. | ||||||